Probably making extra provisions for bad debts.
Likely be more pharmacies going under. Government generic price disclosure policy policy combined with fierce discounting competition has resulted in many pharmacies becoming very marginal and being revalued by lenders. Those that are highly leveraged are most susceptible.
API have been very conservative in their approach to risk and at this time making extra provisions is sensible. It should not have any noticeable operational effect and payment of dividends.
If we see a pull back it may be an opportunity to pick up a few more.
- Forums
- ASX - By Stock
- API
- is there anyone
is there anyone, page-4
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add API (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online